Risk factors for diabetic nephropathy in chronic kidney disease: A narrative review
DOI:
https://doi.org/10.33448/rsd-v14i5.48736Keywords:
Complication, Chronic Kidney Disease, Diabetic Nephropathy.Abstract
Diabetic Nephropathy (DN) is characterized by a group of vast clinical or subclinical manifestations, which affect the Peripheral Nervous System (PNS) as a complication of Diabetes Mellitus (DM). DN affects 20 to 40% of patients with type 1 Diabetes Mellitus (DM) and at least one in three of those with type 2 DM. This study is a narrative review with the purpose of discussing and describing the main risk factors for DN in CKD in its clinical context. The following databases were used: SciElo (Scientific Electronic Library Online) and PubMed (US National Library of Medicine), with language restrictions (Portuguese) and giving priority to articles published between 2010 and 2022. This review highlights the importance of ND in the scenario of morbidity and mortality in patients with DM. In addition to its high prevalence, it is associated with a high frequency of CKD, making it the second most costly diabetic complication. As risk factors are associated with a genetic predisposition, lifestyle habits and chronic diseases, further studies on the molecular bases of the disease, other mediators of kidney damage and therapy are still necessary in order to prevent and delay kidney complications caused by DM.
Downloads
References
Akpinar, et al. (2021). Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy. Brazilian Journal of Nephrology. 43(3), 340-348.
American Diabetes Association. (2012). Standards of medical care in Diabetes2012 (Position Statement). Diabetes Care. 2012; 35(Suppl.l):Sl l-63.
American Diabetes Association. (2012). Standards of medical care in Diabetes. (Position Statement). Diabetes.
Blanco, M. et al. (2017). Evaluación de necesidades paliativas enel paciente conenfermedad renal crónica enhemodiálisis. EnfermNefrol, Madrid, 20(3), 215-220.
Carranza, K. et al. (2015). Aspectos celulares e moleculares da nefropatia diabética, papel do VEGF-A. Nefrología (Madr.) ,Cantabria, 35(2), 131-138.
Colom, C, et al. (2015). Controle glicêmico e complicações crônicas 20 anos após o início do diabetes tipo 1. Resultado de unidade especializada. Avanços em Diabetologia; 31(3), 113–9.
Elsheikh, M .et al. (2019). Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus. BrazilianJournalofNephrology . 2019, 41(4), 587.
Falavigna, M. (2016). Cochrane ACROBAT-NRSI: Avaliando a Qualidade de Estudos Observacionais. Htanalyze: Economia e Gestão em Saúde, [S. l.], p. 10-15, 30.
Flor, L. S., &Campos, M. R. (2017). Prevalência de diabetes mellitus e fatores associados na população adulta brasileira: evidências de um inquérito de base populacional. Revista brasileira epidemiologia, 20(1), 16-29.
Gonzalez,G. et al. (2017). Marcadores de funcionamiento renal en pacientes diabéticos tipo 2. Policlínico “Milanés”. Municipio Matanzas. Rev.Med.Electrón., Matanzas, 39(1), 718-728.
Gonzalez, A. et al. (2020). Caracterización de pacientes diabéticos enhemodiálisisenlaregión de Atacama. Chile. EnfermNefrol,.Madrid, 23(1), 75-82.
Guyton, A,& Hall J. (2009). Tratado de fisiologia médica. Rio de Janeiro:Guanabara Koogan, 2006. Andolfato C, Mariotti MC. Avaliação do paciente em hemodiálise por meio da medida canadense de desempenho ocupacional. 20(1), 1-7.
Kocak, M. Z. et al. (2019). Is Uric Acid elevation a random finding or a causative agent of diabetic nephropathy?.Revista da Associação Médica Brasileira, 65(9), 1155-1160.
Mascheroni, C. A. (2014). Fisiopatologia da hiperfiltração glomerular no diabetes: Parte I. Rev. nefrol. discar. transpl. , Cidade Autônoma de Buenos Aires, 34(6), 130-154.
Miranda, F. et al.(2016). Fatores de progressão da disfunção renal em diabéticos internados na Clínica Médica. Rev. Med.Electrón. 38(6), 805-816. ISSN 1684-1824.
Pereira, A.S.etal.(2018). Metodologia da pesquisa científica. UFSM.
Polanco-Flores, N. A. et al.(2019). Resultados de un programa de deteccióntemprana de nefropatía diabética. Med. interna Méx., Ciudad de México ,35(2), 198-207.
Rioja.J, et al. (2013). Análise preliminar da relação da doença arterial periférica e outros marcadores da arteriosclerose com a nefropatia diabética. Clínica e Pesquisa em Arteriosclerose; 26(5), 229-35.
Vilar, L. et al. (2013). Endocrinologia clínica. (5.ed.), Editora Guanabara Koogan.
Zerquera, T. G. et al. (2016). Caracterização dos diabéticos tipo 2 internados no Centro de Atenção a Diabéticos de Cienfuegos. Rev. Finlay , Cienfuegos, 6(4), 281-289.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 João Neto Marques Borges; Gustavo Henrique Azevedo Borges; Ana Claudia Rodrigues da Silva; Vitor Melo de Oliveira; Kássia Cristina Amaral; Pedro Augusto do Carmo Silva; Pedro Henrique Pereira de Moura; Silvestre Reinaldo da Silva Júnior; Kamila de Freitas Ferreira ; João Pereira Marques
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
